Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABC: Autologous BM-MNC for Limb Ischemia
NCT00539266Phase 3Unknown
- Sponsor
- Leiden University Medical Center
- Start
- Oct 2007
- Primary completion
- Oct 2012
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of autologous bone marrow-derived mononuclear cell in peripheral artery disease (PAD), sponsored by Leiden University Medical Center. Status: unknown.
02
Drugs
autologous bone marrow-derived mononuclear cell
03
Conditions
peripheral artery disease (PAD)
Beyond the preview
Go deeper on NCT00539266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00539266.